Linde De Troyer
Linde De Troyer
1
VIB-KU Leuven Center for Cancer Biology, VIB, 3000 Leuven, Belgium
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
1,2,2,
Peihua Zhao
Peihua Zhao
1
VIB-KU Leuven Center for Cancer Biology, VIB, 3000 Leuven, Belgium
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
1,2,2,
Tibor Pastor
Tibor Pastor
1
VIB-KU Leuven Center for Cancer Biology, VIB, 3000 Leuven, Belgium
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
1,2,2,
Maria Francesca Baietti
Maria Francesca Baietti
1
VIB-KU Leuven Center for Cancer Biology, VIB, 3000 Leuven, Belgium
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
1,2,
Jasmine Barra
Jasmine Barra
1
VIB-KU Leuven Center for Cancer Biology, VIB, 3000 Leuven, Belgium
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
1,2,
Roberto Vendramin
Roberto Vendramin
1
VIB-KU Leuven Center for Cancer Biology, VIB, 3000 Leuven, Belgium
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
1,2,
Ruveyda Dok
Ruveyda Dok
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
2,
Benoit Lechat
Benoit Lechat
1
VIB-KU Leuven Center for Cancer Biology, VIB, 3000 Leuven, Belgium
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
1,2,
Paul Najm
Paul Najm
1
VIB-KU Leuven Center for Cancer Biology, VIB, 3000 Leuven, Belgium
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
1,2,
Delphi Van Haver
Delphi Van Haver
3
VIB Proteomics Core, Albert Baertsoenkaai 3, 9000 Ghent, Belgium
4
Department of Biomolecular Medicine, Ghent University, B-9000 Ghent, Belgium
5
VIB Center for Medical Biotechnology, B-9000 Ghent, Belgium
3,4,5,
Francis Impens
Francis Impens
3
VIB Proteomics Core, Albert Baertsoenkaai 3, 9000 Ghent, Belgium
4
Department of Biomolecular Medicine, Ghent University, B-9000 Ghent, Belgium
5
VIB Center for Medical Biotechnology, B-9000 Ghent, Belgium
3,4,5,
Eleonora Leucci
Eleonora Leucci
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
2,
Anna A Sablina
Anna A Sablina
1
VIB-KU Leuven Center for Cancer Biology, VIB, 3000 Leuven, Belgium
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
1,2,✉
1
VIB-KU Leuven Center for Cancer Biology, VIB, 3000 Leuven, Belgium
2
Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
3
VIB Proteomics Core, Albert Baertsoenkaai 3, 9000 Ghent, Belgium
4
Department of Biomolecular Medicine, Ghent University, B-9000 Ghent, Belgium
5
VIB Center for Medical Biotechnology, B-9000 Ghent, Belgium
✉To whom correspondence should be addressed. Email: anna.sablina@kuleuven.vib.be
2The authors wish it to be known that, in their opinion, the first three authors should be regarded as Joint First Authors.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com